| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000269951.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.016884819 |
Resistant |
| ENSG00000269951.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02903951 |
Resistant |
| ENSG00000269951.1 |
Avagacestat |
Breast invasive carcinoma |
0.030688691 |
Sensitive |
